JP2022502498A5 - - Google Patents

Info

Publication number
JP2022502498A5
JP2022502498A5 JP2021540394A JP2021540394A JP2022502498A5 JP 2022502498 A5 JP2022502498 A5 JP 2022502498A5 JP 2021540394 A JP2021540394 A JP 2021540394A JP 2021540394 A JP2021540394 A JP 2021540394A JP 2022502498 A5 JP2022502498 A5 JP 2022502498A5
Authority
JP
Japan
Prior art keywords
composition according
less
days
treatment cycle
cytarabine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021540394A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502498A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/052952 external-priority patent/WO2020068979A1/en
Publication of JP2022502498A publication Critical patent/JP2022502498A/ja
Publication of JP2022502498A5 publication Critical patent/JP2022502498A5/ja
Pending legal-status Critical Current

Links

JP2021540394A 2018-09-25 2019-09-25 血液疾患の低強度治療 Pending JP2022502498A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862736393P 2018-09-25 2018-09-25
US62/736,393 2018-09-25
US201862772372P 2018-11-28 2018-11-28
US62/772,372 2018-11-28
PCT/US2019/052952 WO2020068979A1 (en) 2018-09-25 2019-09-25 Low-intensity treatment of hematological disorders

Publications (2)

Publication Number Publication Date
JP2022502498A JP2022502498A (ja) 2022-01-11
JP2022502498A5 true JP2022502498A5 (cg-RX-API-DMAC10.html) 2022-09-30

Family

ID=69950910

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021540394A Pending JP2022502498A (ja) 2018-09-25 2019-09-25 血液疾患の低強度治療

Country Status (11)

Country Link
US (3) US20240252522A1 (cg-RX-API-DMAC10.html)
EP (1) EP3856198A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022502498A (cg-RX-API-DMAC10.html)
KR (1) KR20210065962A (cg-RX-API-DMAC10.html)
CN (1) CN113164502A (cg-RX-API-DMAC10.html)
AU (1) AU2019350759A1 (cg-RX-API-DMAC10.html)
BR (1) BR112021005539A2 (cg-RX-API-DMAC10.html)
CA (1) CA3114002A1 (cg-RX-API-DMAC10.html)
IL (1) IL281729A (cg-RX-API-DMAC10.html)
MX (1) MX2021003527A (cg-RX-API-DMAC10.html)
WO (1) WO2020068979A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018009463A8 (pt) * 2015-11-11 2019-02-26 Celator Pharmaceuticals Inc ensaios e métodos para selecionar um regime de tratamento para um sujeito com leucemia
US20240252522A1 (en) * 2018-09-25 2024-08-01 Celator Pharmaceuticals, Inc. Low-intensity treatment of hematological disorders
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
CA3216716A1 (en) 2021-05-03 2022-11-10 Tim BERGBREDE Composition comprising an inhibitor of mitochondrial transcription

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
EP1432403B1 (en) 2001-10-03 2010-07-28 Celator Pharmaceuticals, Inc. Liposome loading with metal ions
US20050118250A1 (en) 2001-11-13 2005-06-02 Paul Tardi Lipid carrier compositions with enhanced blood stability
JP4972545B2 (ja) 2004-04-22 2012-07-11 セレーター ファーマスーティカルズ、インク. アントラサイクリン系薬剤及びシチジンアナログのリポソーム製剤
PT2120568T (pt) 2007-02-16 2017-12-04 Celator Pharmaceuticals Inc Rácios de fármacos fixados para tratamento de cancros hematopoiéticos e desordens proliferativas
PT2768484T (pt) 2011-10-21 2019-10-28 Jazz Pharmaceuticals Res Llc Lipossomas liofilizados
BR112018009463A8 (pt) * 2015-11-11 2019-02-26 Celator Pharmaceuticals Inc ensaios e métodos para selecionar um regime de tratamento para um sujeito com leucemia
KR20230100748A (ko) * 2016-07-28 2023-07-05 노파르티스 아게 키메라 항원 수용체 및 pd-1 억제제의 조합 요법
CN110088166B (zh) 2016-12-01 2021-06-08 Jxtg能源株式会社 全芳香族液晶聚酯树脂
US20240252522A1 (en) * 2018-09-25 2024-08-01 Celator Pharmaceuticals, Inc. Low-intensity treatment of hematological disorders
US11980636B2 (en) * 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders

Similar Documents

Publication Publication Date Title
JP2023041862A5 (cg-RX-API-DMAC10.html)
JP2023541432A5 (cg-RX-API-DMAC10.html)
JP2023541430A5 (cg-RX-API-DMAC10.html)
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
BR0207024A (pt) Medicamento com ação inicial rápida para o tratamento de disfunção sexual
JP2021512149A5 (cg-RX-API-DMAC10.html)
RU2010147287A (ru) Комбинированная композиция
JP2005506367A5 (cg-RX-API-DMAC10.html)
JP3465824B2 (ja) 腫瘍治療用医薬組成物
JP2010519224A5 (cg-RX-API-DMAC10.html)
Oguchi et al. Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis
JP2023552700A5 (cg-RX-API-DMAC10.html)
JP2024516795A5 (cg-RX-API-DMAC10.html)
JP2019515909A5 (cg-RX-API-DMAC10.html)
WO2011159100A2 (ko) 항암 활성을 나타내는 약제학적 조성물
Murty Antiepileptic overdose
JP2018138596A5 (cg-RX-API-DMAC10.html)
JP2024542984A5 (cg-RX-API-DMAC10.html)
JP2023505301A5 (cg-RX-API-DMAC10.html)
JP2016505050A5 (cg-RX-API-DMAC10.html)
JPWO2021045159A5 (cg-RX-API-DMAC10.html)
CN107137417B (zh) 一种用于治疗恶病质的药物组合物及其应用
JP2011500589A5 (cg-RX-API-DMAC10.html)
JP2014534229A5 (cg-RX-API-DMAC10.html)
JP2020526575A5 (cg-RX-API-DMAC10.html)